AMAG Pharmaceuticals, Inc.

NASDAQ: AMAG
$10.11
+$0.66 (+7.0%)
Closing price September 18, 2020
Tuesday's top analyst upgrades and downgrades included Best Buy, CarMax, Elanco Animal Health, General Motors, Home Depot, Intercontinental Exchange, JD.com, McDonald's, Procter & Gamble and Vonage.
Wednesday's top analyst upgrades, downgrades and initiations included Advanced Micro Devices, Apple, Biomarin, Corning, Electronic Arts, FireEye, Grubhub, Nordstrom, NXP Semiconductors, Shopify and...
Short sellers seem to have many emerging and speculative biotech stocks targeted for termination. Here are eight of them against which short sellers are betting the farm.
The top analyst upgrades, downgrades and initiations seen on Thursday included Allstate, Corning, DexCom, Lam Research, On Deck, Qualcomm, Spotify, Western Digital and Whiting Petroleum.
The top analyst upgrades, downgrades and initiations on Tuesday included Agilent Technologies, Allergan, Beyond Meat, Canopy Growth, Dollar Tree, Facebook, Luckin Coffee, Lyft, Mylan, Symantec,...
The top analyst upgrades, downgrades and initiations seen on Friday included Activision Blizzard, BioMarin Pharmaceuticals, Ciena, Delta Air Lines, GlaxoSmithKline, Procter & Gamble, Regeneron...
The top analyst upgrades, downgrades and initiations seen on Tuesday included AbbVie, AMAG Pharmaceuticals, Crocs, HCA, Kellogg, Kosmos Energy, Mylan, Pandora Media and Square.
The top analyst upgrades, downgrades and other research calls from Monday include Applied Materials, Campbell Soup, Ceridien HCM, Dillard's, Energizer, nLIGHT, Snap, Turtle Beach
The top analyst upgrades, downgrades and other research calls from Monday include AMAG Pharmaceuticals, Foot Locker, Groupon, H&R Block, McDonald's, Teradata, Under Armour and Valeant...
AMAG Pharmaceuticals saw its shares skyrocket early on Thursday after the company announced that it received an FDA approval.
The top analyst upgrades, downgrades and other research calls from Thursday include AMAG Pharmaceuticals, Baidu, Cisco, General Electric, Honeywell, 3M, Salesforce.com, SunPower and United...
Johnson &; Johnson, Gilead Sciences and Amicus Therapeutics are among companies expecting clinical trial and FDA updates in February.
AMAG Pharmaceuticals shares took a sharp turn down after the company reported top-line results from its most recent pharmacokinetic study.
The top analyst upgrades, downgrades and initiations on Tuesday include American Express, Goldman Sachs, Illumina, PayPal, Trivago and Williams Companies.
The top analyst upgrades, downgrades and initiations seen on Wednesday morning include Abercrombie & Fitch, Altria, Anthem, United Continental, Blackstone and AMAG Pharmaceuticals.